---
title: "India's Natco Pharma plunges on weak quarterly earnings"
date: "2025-02-13 12:21:01"
summary: "** Shares of India's Natco Pharma drop 16.5% to 1017 rupees, marking their biggest intraday loss since debut ** The drugmaker's Q3 consol net profit fell 37.5% y/y, while rev dropped 37.4% y/y** Stock sees steepest fall since June 5, 2024, set for fifth straight session of losses, if current..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Shares of India's Natco Pharma drop 16.5% to 1017 rupees, marking their biggest intraday loss since debut

\*\* The drugmaker's Q3 consol net profit fell 37.5% y/y, while rev dropped 37.4% y/y

\*\* Stock sees steepest fall since June 5,Â 2024, set for fifth straight session of losses, if current trend holds

\*\* NATP stock has lost ~27% so far in 2025

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P40BD:0-india-s-natco-pharma-plunges-on-weak-quarterly-earnings/)
